Literature DB >> 11372694

Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis.

A T Cohen, C S Bailey, R Alikhan, D J Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372694

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  14 in total

Review 1.  Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Authors:  Roel Fijn; Rinco Th Koorevaar; Jacobus R Brouwers
Journal:  Pharm World Sci       Date:  2003-08

Review 2.  The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests.

Authors:  Behrouz Kassaï; Nirav R Shah; Alain Leizorovicza; Michel Cucherat; Francois Gueyffier; Jean-Pierre Boissel
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

Review 3.  Direct oral anticoagulants for extended-duration thromboprophylaxis in hospitalized medically ill patients: are we there yet?

Authors:  Majed S Al Yami; Osamah M Alfayez; Sawsan M Kurdi; Razan Alsheikh
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

4.  The incidence of deep vein thrombosis and pulmonary embolism following cast immobilisation and early functional bracing of Tendo Achilles rupture without thromboprophylaxis.

Authors:  G J Heyes; A Tucker; A L R Michael; R G H Wallace
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-05       Impact factor: 3.693

Review 5.  The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis.

Authors:  Woo-Suk Lee; Kang-Il Kim; Han-Jun Lee; Hee-Soo Kyung; Seung-Suk Seo
Journal:  Clin Orthop Relat Res       Date:  2013-05       Impact factor: 4.176

Review 6.  Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.

Authors:  Plamen Kinov; Panayot P Tanchev; Martin Ellis; Gershon Volpin
Journal:  Int Orthop       Date:  2013-10-11       Impact factor: 3.075

7.  Performance measures for improving the prevention of venous thromboembolism: achievement in clinical practice.

Authors:  Kenneth C Wilson; Geno J Merli
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

8.  Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey.

Authors:  B A Rogers; S Phillips; J Foote; K J Drabu
Journal:  Ann R Coll Surg Engl       Date:  2010-07-02       Impact factor: 1.891

Review 9.  A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.

Authors:  Sam Schulman; Ammar Majeed
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

10.  Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).

Authors:  Geoffrey D Barnes; Scott Kaatz; Vlad Golgotiu; Xiaokui Gu; Adam Leidal; Abdallah Kobeissy; Brian Haymart; Eva Kline-Rogers; Jay Kozlowski; Steve Almany; Tom Leyden; James B Froehlich
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.